Now showing items 1-4 of 4

    • FGF-affinity chromatography 

      Mckeehan, Wallace L.; Luo, Yongde (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2004-11-02)
      The present invention relates to a method and apparatus for isolating anticoagulant heparin or heparan sulfate by binding the anticoagulant heparin or anticoagulant heparan sulfate onto an affinity matrix and separating ...
    • Method and compositions for inhibiting thrombin-induced coagulation 

      Davis, Stacey; Hook, Magnus A. O. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2004-12-28)
      A method of achieving safe and effective treatment or prevention of potentially harmful blood clots, or in inhibiting the coagulation of blood when so desired such as during a wide array of disease conditions including ...
    • Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative 

      Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2012-12-18)
      Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
    • Peptide inhibitor of fibrinogen blood clotting 

      Hook, Magnus A.; Yang, Vivian W-C (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2002-07-02)
      A method of inhibiting fibrin clot formation is provided. The decorin protein, peptide, or related fragments are found to bind fibrinogen in the presence of Zinc (Zn2+), thus preventing the formation of fibrin clots. The ...